newsfilter
← Latest News
GlobeNewswire·

Dova Pharmaceuticals to be Acquired by Swedish Orphan Biovitrum AB (Sobi)

Consideration of up to $29.00 per share includes $27.50 per share in upfront cash and an additional $1.50 per share upon regulatory approval of DOPTELET® for chemotherapy-induced thrombocytopenia...